Thus, Fan Y et al., have recently reported that the survival time of patients with pulmonary NETs is significantly associated with PD-L1 expression by tumor cells and PD-1 expression by tumor-infiltrating lymphocytes, and that patients with negative PD-1/PD-L1 expression have better prognoses33. This evidence concerns the gene PDCD1 and neoplasm.